Todd Cohen, Adam Keil On Pancreatic Cancer Awareness Walk

Todd Cohen and Adam Keil stopped by to talk about the Second Annual Purple Stride New Jersey for pancreatic cancer awareness.

Second Annual Purple Stride New Jersey ( Sunday Nov. 6th, 8:30 Registration, 10 a.m. 5 run/walk- Mack Cali Business Complex in Parsippany, NJ- Adult 5K Walk - $25 (Registration is $30 on event day), Adult 5K Run - $30 (Registration is $35 on event day), Youth (age 3 to 12) - $10- Raised over $200,000 this year and have 900 people already registered

PurpleLight National Vigil for Hope ( - Nov. 20th at 5 p.m. at Papaianni Park, Edison, NJ - A way to honor loved ones fighting pancreatic cancer and for those who have lost the fight

ABOUT PANCREATIC CANCERPancreatic cancer is the fourth leading cause of cancer death in the United States. 74 percent of patients will die in the first 12 months of diagnosis and the five year survival rate is less than 6 percent. And despite the statistics, pancreatic cancer is the most under-funded among leading cancer killers with less than 2 percent of the National Cancer Institute's annual research budget. Pancreatic cancer is one of the few cancers for which the survival rate has not improved substantially over the past forty years.

SYMPTOMS OF PANCREATIC CANCERThe symptoms are back or abdominal pain, digestive issues or unexplained weight loss, which may indicate a number of other conditions. The symptom that often triggers a pancreatic cancer diagnosis is jaundice, which is yellowing of the skin and eyes.

WHO IS AT RISK FOR PANCREATIC CANCERMany risk factors are still undefined, but we do know that 10 percent are said to have a hereditary (or familial) link. We also know the incidence among African-Americans is 50-90 percent higher than any other ethnic group in the United States. And there is an even greater risk of pancreatic cancer among Ashkenazi Jews. As with many other cancers, there is a link to smoking in about 20-30 percent of pancreatic cancer cases. We need more funding for pancreatic cancer research to identify other causes of this terrible disease and to learn more about these risk factors.

ABOUT THE PANCREATIC CANCER ACTION NETWORKThe Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to increase the survival rate for people diagnosed with this devastating disease through a bold initiative--The Vision of Progress: Double the Pancreatic Cancer Survival Rate by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival.

WHY IS PANCREATIC CANCER SO DEADLY? The mortality for pancreatic cancer is so high because patients are typically diagnosed when the cancer has already spread to other organs, and there are few effective treatment options. We need more funding for pancreatic cancer research to enable scientists to find early detection methods and give patients a fighting chance.

WHY IS PANCREATIC CANCER SO UNDER-FUNDED COMPARED WITH OTHER LEADING CANCER KILLERS? The sad truth is that there are few survivors to advocate for more research funding. The squeaky wheel gets the grease and we have seen that happen with other diseases, such as breast cancer and AIDS, and there are not enough survivors to act as a squeaky wheel on behalf of other pancreatic cancer patients.

Copyright © 2014, Los Angeles Times